We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
100 hedge funds and large institutions have $385M invested in Intra-Cellular Therapies Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more call options, than puts
Call options by funds: $6.76M | Put options by funds: $1.5M
21% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 29
15% less funds holding
Funds holding: 117 → 100 (-17)
19% less capital invested
Capital invested by funds: $476M → $385M (-$91.7M)
59% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 27
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
100
Holders Change
-17
Holders Change %
-14.53%
% of All Funds
2.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
35
Reduced
29
Closed
27
Calls
$6.76M
Puts
$1.5M
Net Calls
+$5.26M
Net Calls Change
+$3.75M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$10.7M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$7.59M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.94M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.06M |
| 5 |
Goldman Sachs
New York
|
+$5.19M |
Top Sellers
| 1 |
CCI
Columbus Circle Investors
|
-$6.19M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$6.05M |
| 3 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
-$5.85M |
| 4 |
Millennium Management
New York
|
-$5.73M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.44M |
